As one of the leading suppliers of peptide APIs worldwide, AmbioPharm provides rigid quality control, SOPs, training, and rigorous testing.


FDA-Inspected Peptide Manufacturing

FDA-Inspected Peptide Manufacturing

AmbioPharm operates an FDA-inspected U.S. based manufacturing site in North Augusta, SC. The facility is capable of producing peptide API’s from gram to multi-kilogram quantities.

The U.S. Food & Drug Administration (FDA) performs Pre-Approval Inspections (PAIs) and regular inspections of facilities under the Federal Food, Drug, and Cosmetic (FD&C) Act. AmbioPharm complies with all FDA inspections and PAIs while demonstrating a consistent commitment to the highest levels of quality and compliance.

View the FDA Drug Establishments Current Registration Site
(Search AmbioPharm)

Rigid Quality Control

Rigid Quality Control

Analytical Testing
  • Purity: (Ultra) High Pressure Liquid Chromatography (UPLC/HPLC)
  • Residual Solvents: Gas Chromatography (GC)
  • Molecular Weight: ESI- Mass Spectroscopy
  • Related-Substances: Liquid Chromatography-Mass Spectrometry (LC-MS)
  • Counter Ion Content: Ion Chromatography (IC)
  • Size Exclusion Chromatography (SEC)
  • Water Content: Karl Fischer (KF)
  • Peptide Content: Nitrogen Content
  • Amino Acid Composition: Amino Acid Analysis (AAA)
  • Bioburden
  • Endotoxin